Ottawa, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The global multiple modalities in oncology market is advancing rapidly, with revenues expected to reach hundreds of millions between 2025 and 2034. This ...
Multiple modalities mean more options for students–and more options for students can translate to greater enrollment and diversity. We’re already seeing the proof of this concept. When most ...
Multiple modalities mean more options for students–and more options for students can translate to greater enrollment and diversity. We’re already seeing the proof of this concept. When most ...
Optically guided surgical approach and the outcome of early-stage oral cancers. Background: We started a prospective cohort study in August 2003 to evaluate the utility of whole- body cancer screening ...
Additional oral presentations explore odronextamab in areas of high unmet need, including the primary analysis in diffuse large B-cell lymphoma progressing after CAR-T therapy and first results in ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Please provide your email address to receive an email when new articles are posted on . Among patients with myositis, younger individuals with dermatomyositis are more likely to experience pain, while ...
(MENAFN- GlobeNewsWire - Nasdaq) The growth of the multiple modalities in oncology market is driven by the growing incidence of cancer and advances in precision medicine and diagnostics, reports ...
Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in first ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback